Soligenix (SNGX) Stock Forecast, Price & News

Soligenix (NASDAQ:SNGX) Frequently Asked Questions

Is Soligenix a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Soligenix in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Soligenix stock.
View analyst ratings for Soligenix or view top-rated stocks.

When is Soligenix's next earnings date?

Soligenix is scheduled to release its next quarterly earnings announcement on Friday, August 12th 2022.
View our earnings forecast for Soligenix.

How were Soligenix's earnings last quarter?

Soligenix, Inc. (NASDAQ:SNGX) released its earnings results on Tuesday, March, 29th. The biopharmaceutical company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by $0.03. The biopharmaceutical company earned $0.28 million during the quarter, compared to analyst estimates of $0.20 million. Soligenix had a negative net margin of 1,710.71% and a negative trailing twelve-month return on equity of 121.28%.
View Soligenix's earnings history.

What price target have analysts set for SNGX?

2 analysts have issued 1-year price objectives for Soligenix's shares. Their forecasts range from $1.50 to $3.75. On average, they expect Soligenix's share price to reach $2.63 in the next year. This suggests a possible upside of 338.2% from the stock's current price.
View analysts' price targets for Soligenix or view top-rated stocks among Wall Street analysts.

Who are Soligenix's key executives?

Soligenix's management team includes the following people:

• Dr. Christopher J. Schaber Ph.D., Chairman, CEO & Pres (Age 56, Pay $611.46k) (LinkedIn Profile)
• Mr. Jonathan L. Guarino CPA, CGMA, Sr. VP, CFO & Corp. Sec. (Age 49, Pay $292.29k) (LinkedIn Profile)
• Dr. Oreola Donini Ph.D., Sr. VP & Chief Scientific Officer (Age 50, Pay $344.55k)
• Dr. Richard C. Straube M.D., MSc., Sr. VP & Chief Medical Officer (Age 70, Pay $206.05k)
• Mr. Richard L. Dunning, Exec. Officer (Age 76)

Who are some of Soligenix's key competitors?

Some companies that are related to Soligenix include Paratek Pharmaceuticals (PRTK), NervGen Pharma (NGENF), Anixa Biosciences (ANIX), Clovis Oncology (CLVS), Daré Bioscience (DARE), Leap Therapeutics (LPTX), Fortress Biotech (FBIO), Hookipa Pharma (HOOK), Ardelyx (ARDX), Akouos (AKUS), DURECT (DRRX), Puma Biotechnology (PBYI), Assembly Biosciences (ASMB), Trevi Therapeutics (TRVI) and Eliem Therapeutics (ELYM).
View all of SNGX's competitors.

What other stocks do shareholders of Soligenix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Soligenix investors own include VBI Vaccines (VBIV), T2 Biosystems (TTOO), Trevena (TRVN), Vaxart (VXRT), OPKO Health (OPK), SCYNEXIS (SCYX), Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE) and Actinium Pharmaceuticals (ATNM).

What is Soligenix's stock symbol?

Soligenix trades on the NASDAQ under the ticker symbol "SNGX."

Who are Soligenix's major shareholders?

Soligenix's stock is owned by a variety of retail and institutional investors. Top institutional investors include ARGI Investment Services LLC (0.11%). Company insiders that own Soligenix stock include Christopher J Schaber, Jerome B Zeldis, Jonathan L Guarino and Richard Straube.
View institutional ownership trends for Soligenix.

Which institutional investors are buying Soligenix stock?

SNGX stock was acquired by a variety of institutional investors in the last quarter, including ARGI Investment Services LLC. Company insiders that have bought Soligenix stock in the last two years include Christopher J Schaber, Jerome B Zeldis, Jonathan L Guarino, and Richard Straube.
View insider buying and selling activity for Soligenix or or view top insider-buying stocks.

How do I buy shares of Soligenix?

Shares of SNGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Soligenix's stock price today?

One share of SNGX stock can currently be purchased for approximately $0.60.

How much money does Soligenix make?

Soligenix has a market capitalization of $25.79 million and generates $820 thousand in revenue each year. The biopharmaceutical company earns $-13.42 million in net income (profit) each year or ($0.350010) on an earnings per share basis.

How many employees does Soligenix have?

Soligenix employs 13 workers across the globe.

When was Soligenix founded?

Soligenix was founded in 1987.

What is Soligenix's official website?

The official website for Soligenix is www.soligenix.com.

How can I contact Soligenix?

Soligenix's mailing address is 29 EMMONS DRIVE SUITE B-10, PRINCETON NJ, 08540. The biopharmaceutical company can be reached via phone at (609) 538-8200, via email at [email protected], or via fax at 609-452-6467.